Arcus Biosciences Announces New Employment Inducement Grants
Stocks in this Quantisnow insightHealth Care
Historical context for RCUS
Across the 24 sessions after earlier RCUS headlines, the stock closed higher 12 times and lower 12 times, with a median move of 4.1% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | RCUS | SPY |
|---|---|---|---|
| Jun 25, 2026 | Arcus Biosciences Announces New Employment Inducement Grants | +5.0% | +0.1% |
| Jun 10, 2026 | Arcus Biosciences Announces New Employment Inducement Grants | -6.4% | -1.6% |
| May 27, 2026 | Arcus Biosciences to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference | -0.7% | -0.0% |
| May 18, 2026 | Truist resumed coverage on Arcus Biosciences with a new price target | -1.6% | -0.1% |
| May 6, 2026 | Arcus Biosciences Reports First-Quarter 2026 Financial Results and Provides a Pipeline Update | -0.2% | +1.4% |
| Apr 27, 2026 | Arcus Biosciences Announces New Employment Inducement Grants | -2.2% | +0.2% |
Quantisnow market dataNYSE
RCUS
Arcus Biosciences Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2018
Get push alerts for RCUS
Full RCUS profile on Quantisnow Follow RCUS and get a push notification the moment its next story breaks.